The emerging role of microRNAs in Alzheimer's disease

MicroRNAs (miRNAs) are small non-coding RNA which have been shown to regulate gene expression. The alteration ofmiRNAs expression has been associated with several pathological processes, including neurodegeneration. In the search for easily accessible and non-invasive biomarkers for Alzheimer's disease (AD) diagnosis and prognosis, circulating miRNAs are among the most promising candidates. Some of them have been consistently identified as AD-specific miRNAs and their targets also seem implicated in pathophysiological processes underlying AD. Here, we review the emerging role for miRNA in AD, giving an overview on general miRNAs biology, their implications in AD pathophysiology and their potential role as future biomarkers.

[1]  D. Kapogiannis,et al.  Insulin resistance in Alzheimer's disease , 2017, Translational research : the journal of laboratory and clinical medicine.

[2]  Dong Hee Kim,et al.  Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. , 2014, Gene.

[3]  Gunhild Waldemar,et al.  The potential of microRNAs as biofluid markers of neurodegenerative diseases – a systematic review , 2014, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[4]  Klaus-Peter Lesch,et al.  Epigenetically regulated microRNAs in Alzheimer's disease , 2014, Neurobiology of Aging.

[5]  G. Calin,et al.  Clinical relevance of circulating cell-free microRNAs in cancer , 2014, Nature Reviews Clinical Oncology.

[6]  Paul Edison,et al.  Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging , 2014, Alzheimer's & Dementia.

[7]  Gennaro Pagano,et al.  Autonomic dysfunction in Alzheimer's disease: tools for assessment and review of the literature. , 2014, Journal of Alzheimer's disease : JAD.

[8]  Y. Torrente,et al.  The involvement of microRNAs in neurodegenerative diseases , 2013, Front. Cell. Neurosci..

[9]  C. Jack,et al.  Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.

[10]  Alzheimer’s as a metabolic disease , 2013, Biogerontology.

[11]  E. Goodall,et al.  Neuronal dark matter: the emerging role of microRNAs in neurodegeneration , 2013, Front. Cell. Neurosci..

[12]  S. Hébert,et al.  Circulating microRNAs in Alzheimer’s disease: the search for novel biomarkers , 2013, Front. Mol. Neurosci..

[13]  P. Filardi,et al.  β-adrenergic receptors and G protein-coupled receptor kinase-2 in Alzheimer's disease: a new paradigm for prognosis and therapy? , 2013, Journal of Alzheimer's disease : JAD.

[14]  W. Lukiw,et al.  microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). , 2012, International journal of biochemistry and molecular biology.

[15]  W. Lukiw,et al.  Spreading of Alzheimer's disease inflammatory signaling through soluble micro‐RNA , 2012, Neuroreport.

[16]  R. Malenka,et al.  An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration , 2012, Nature Neuroscience.

[17]  G. Jicha,et al.  Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease , 2012, Experimental Neurology.

[18]  C. Ramírez,et al.  miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression , 2012, Experimental Neurology.

[19]  N. Schonrock,et al.  MicroRNA networks surrounding APP and amyloid-β metabolism — Implications for Alzheimer's disease , 2012, Experimental Neurology.

[20]  S. Hébert,et al.  MicroRNAs in Alzheimer's disease , 2012, Neurobiology of Disease.

[21]  X. Chen,et al.  Secreted microRNAs: a new form of intercellular communication. , 2012, Trends in cell biology.

[22]  Walter J. Lukiw,et al.  Regulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer’s Disease (AD) Brain , 2012, Molecular Neurobiology.

[23]  J. Schneider,et al.  National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.

[24]  P. Falkai,et al.  microRNA‐34c is a novel target to treat dementias , 2011, The EMBO journal.

[25]  Hyoung-Gon Lee,et al.  The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations , 2011, The Lancet Neurology.

[26]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[27]  Jürgen Götz,et al.  Target Gene Repression Mediated by miRNAs miR-181c and miR-9 Both of Which Are Down-regulated by Amyloid-β , 2011, Journal of Molecular Neuroscience.

[28]  Peter T. Nelson,et al.  Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter , 2011, Acta Neuropathologica.

[29]  P. Nelson,et al.  MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. , 2010, Journal of Alzheimer's disease : JAD.

[30]  Walter J. Lukiw,et al.  Micro-RNA abundance and stability in human brain: Specific alterations in Alzheimer's disease temporal lobe neocortex , 2009, Neuroscience Letters.

[31]  A. Delacourte,et al.  Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression , 2008, Proceedings of the National Academy of Sciences.

[32]  A. Roses,et al.  Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .

[33]  Hyman M. Schipper,et al.  MicroRNA Expression in Alzheimer Blood Mononuclear Cells , 2007, Gene regulation and systems biology.

[34]  C. Sander,et al.  A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.

[35]  Simon Lovestone,et al.  p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells , 2007, Neuroscience Letters.

[36]  Konstantin Khrapko,et al.  A microRNA array reveals extensive regulation of microRNAs during brain development. , 2003, RNA.

[37]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[38]  I. Deary,et al.  Insulin resistance , 1996 .

[39]  BLOOD SERUM.* , 2022 .